1AD 0.00% 2.1¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-6

  1. 23,088 Posts.
    lightbulb Created with Sketch. 827
    Certainly not a one trick pony. Lots of ground work being done which will reap serious benefits over many years. Not sure where the SP will head in the near term however in the medium to long term the price really could be anything. Especially with the sector being so hot atm. Hopefully some more announcement to really get those oppies in the money over the next few weeks.
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $12.50M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 36918 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 950000 2
View Market Depth
Last trade - 16.25pm 03/09/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.